In this webinar we will elaborate how PureHale®, an innovative Bag-on-Valve based technology, adds value to the treatment of upper respiratory conditions. We will introduce a new model that combines a Next Generation Impactor (NGI), and an altered setup of CFPD from the University of Cyprus that enables the assessment of deposition patterns of formulations in the upper airways.
Finally, we will present an outlook on the potential use of PureHale® for preventive treatments of upper respiratory tract conditions.
Register now for Aptar Pharma’s free webinar on September 16, 2021:
